Simplex Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-361
Closed -$649K 8970
2020
Q2
$649K Buy
361
+105
+41% +$1.46K ﹤0.01% 2611
2020
Q1
$182K Buy
256
+115
+82% +$1.44K ﹤0.01% 3717
2019
Q4
$336K Sell
141
-128
-48% -$3.53K ﹤0.01% 3160
2019
Q3
$721K Buy
269
+71
+36% +$1.99K ﹤0.01% 2265
2019
Q2
$537K Sell
198
-14
-7% -$439 ﹤0.01% 2492
2019
Q1
$735K Hold
212
﹤0.01% 2265
2018
Q4
$413K Sell
212
-41
-16% -$843 ﹤0.01% 2413
2018
Q3
$673K Buy
253
+8
+3% +$261 ﹤0.01% 2305
2018
Q2
$925K Sell
245
-94
-28% -$3.6K ﹤0.01% 1868
2018
Q1
$233K Buy
339
+29
+9% +$1.27K 0.01% 1144
2017
Q4
$172K Buy
310
+103
+50% +$5.21K 0.01% 1385
2017
Q3
$89K Sell
207
-155
-43% -$9.1K ﹤0.01% 1819
2017
Q2
$53K Buy
362
+294
+432% +$11.8K ﹤0.01% 2353
2017
Q1
$14K Sell
68
-777
-92% -$24.7K ﹤0.01% 3666
2016
Q4
$108K Buy
845
+539
+176% +$10.5K 0.01% 1474
2016
Q3
$191K Buy
+306
New +$7.18K 0.01% 1067
2016
Q2
Sell
-200
Closed -$330K 6739
2016
Q1
$330K Sell
200
-84
-30% -$2.67K 0.03% 610
2015
Q4
$207K Buy
284
+182
+178% +$8.82K 0.02% 855
2015
Q3
$121K Buy
102
+63
+162% +$3.04K 0.01% 1275
2015
Q2
$34K Buy
39
+4
+11% +$161 ﹤0.01% 1995
2015
Q1
$24K Buy
+35
New +$1.2K ﹤0.01% 2188

Simplex Trading's PTLA Position: Q3 2020 in Review

Simplex Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 576 shares — an estimated $10K sold.

Simplex Trading first reported a position in PTLA in Q4 2014 and held it in 20 quarters. The position peaked at $1.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Simplex Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Simplex Trading sold 576 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
  • Simplex Trading first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
  • Simplex Trading's Portola Pharmaceuticals, Inc. position peaked at $1.3M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.